Effector Therapeutics Inc
(EFTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,251 | -12,130 | -6,582 | -2 | 20,065 |
| Depreciation Amortization | 19 | 13 | 7 | 0 | 127 |
| Other Working Capital | -2,092 | 260 | 813 | 1 | 605 |
| Other Operating Activity | -14,556 | 1,044 | 765 | 0 | 505 |
| Operating Cash Flow | $-19,880 | $-10,813 | $-4,997 | $-1 | $21,302 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 601 | 607 | 607 | 0 | N/A |
| Investing Cash Flow | $601 | $607 | $607 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,835 | 19,835 | 19,889 | N/A | N/A |
| Debt Repayment | -13,940 | -13,940 | -13,940 | N/A | -500 |
| Common Stock Issued | 52,936 | 16 | 0 | N/A | 108 |
| Other Financing Activity | 0 | -41 | -1 | 13 | 0 |
| Financing Cash Flow | $58,831 | $5,870 | $5,948 | $13 | $-392 |
| Beginning Cash Position | 15,216 | 15,216 | 15,216 | 0 | 3,427 |
| End Cash Position | 54,768 | 10,880 | 16,774 | 12 | 24,337 |
| Net Cash Flow | $39,552 | $-4,336 | $1,558 | $12 | $20,910 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,880 | -10,813 | -4,997 | -1 | 21,302 |
| Capital Expenditure | -6 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -19,886 | -10,813 | -4,997 | -1 | 21,302 |